XSpray Pharma AB (OSTO:XSPRAY) Days Sales Outstanding : 0.00 (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is XSpray Pharma AB Days Sales Outstanding?

XSpray Pharma AB's average Accounts Receivable for the three months ended in Mar. 2025 was kr3.89 Mil. XSpray Pharma AB's Revenue for the three months ended in Mar. 2025 was kr0.00 Mil.

The historical rank and industry rank for XSpray Pharma AB's Days Sales Outstanding or its related term are showing as below:

During the past 10 years, XSpray Pharma AB's highest Days Sales Outstanding was 986.29. The lowest was 18.85. And the median was 35.40.

OSTO:XSPRAY's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 69.43
* Ranked among companies with meaningful Days Sales Outstanding only.

XSpray Pharma AB's Days Sales Outstanding stayed the same from Mar. 2024 (0.00) to Mar. 2025 (0.00).

XSpray Pharma AB Days Sales Outstanding Historical Data

The historical data trend for XSpray Pharma AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XSpray Pharma AB Days Sales Outstanding Chart

XSpray Pharma AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

XSpray Pharma AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of XSpray Pharma AB's Days Sales Outstanding

For the Biotechnology subindustry, XSpray Pharma AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XSpray Pharma AB's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XSpray Pharma AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where XSpray Pharma AB's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

XSpray Pharma AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

XSpray Pharma AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (4.165	+	4.018)	/	2 )	/	0	*	365
=	4.0915					/	0	*	365
=	N/A

XSpray Pharma AB's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (4.018	+	3.758)	/	2 )	/	0	*	365 / 4
=	3.888					/	0	*	365 / 4
=	N/A

XSpray Pharma AB (OSTO:XSPRAY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

XSpray Pharma AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of XSpray Pharma AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

XSpray Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

0GHZ:UK 6XP:Germany

Address

Scheeles vag 2, Solna, SWE, SE-171 65

Website

https://www.xspraypharma.com

XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.

XSpray Pharma AB Headlines

No Headlines